Kepivance Interactions
There are 135 drugs known to interact with Kepivance (palifermin). Of the total drug interactions, 1 is major, and 134 are moderate.
- View all 135 medications that may interact with Kepivance
Most frequently checked interactions
View interaction reports for Kepivance (palifermin) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- acyclovir
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- amlodipine
- ampicillin / sulbactam
- Arava (leflunomide)
- Arcapta (indacaterol)
- Atarax (hydroxyzine)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- axicabtagene ciloleucel
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Barhemsys (amisulpride)
- belantamab mafodotin
- Belsomra (suvorexant)
- Benemid (probenecid)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bosulif (bosutinib)
- Bumex (bumetanide)
- Buphenyl (sodium phenylbutyrate)
- BuSpar (buspirone)
- Cardizem LA (diltiazem)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Cerezyme (imiglucerase)
- chloramphenicol ophthalmic
More about Kepivance (palifermin)
- Kepivance consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous uncategorized agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.